메뉴 건너뛰기




Volumn 13, Issue 3, 2007, Pages 1010-1018

Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1α protein accumulation by NSC 644221

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; DNA TOPOISOMERASE (ATP HYDROLYSING); HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; LUCIFERASE; MESSENGER RNA; METHIONINE; NSC 644221; PROTEASOME INHIBITOR; PROTEIN INHIBITOR; PROTEIN P21; SMALL INTERFERING RNA; SULFUR 35; UNCLASSIFIED DRUG; VASCULOTROPIN;

EID: 33847421328     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2301     Document Type: Article
Times cited : (48)

References (27)
  • 1
    • 0032053823 scopus 로고    scopus 로고
    • The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
    • Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998;58:1408-16.
    • (1998) Cancer Res , vol.58 , pp. 1408-1416
    • Brown, J.M.1    Giaccia, A.J.2
  • 2
    • 0142166332 scopus 로고    scopus 로고
    • Targeting HIF-1 for cancer therapy
    • Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32.
    • (2003) Nat Rev Cancer , vol.3 , pp. 721-732
    • Semenza, G.L.1
  • 3
    • 0036359548 scopus 로고    scopus 로고
    • Hypoxia - a key regulatory factor in tumour growth
    • Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
    • (2002) Nat Rev Cancer , vol.2 , pp. 38-47
    • Harris, A.L.1
  • 5
    • 0037008770 scopus 로고    scopus 로고
    • Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway
    • Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 2002;31:27975-81.
    • (2002) J Biol Chem , vol.31 , pp. 27975-27981
    • Treins, C.1    Giorgetti-Peraldi, S.2    Murdaca, J.3    Semenza, G.L.4    Van Obberghen, E.5
  • 6
    • 0036569704 scopus 로고    scopus 로고
    • Geldanamycin induces degradation of hypoxia-inducible factor 1α protein via the proteosome pathway in prostate cancer cells
    • Mabjeesh NJ, Post DE, Willard MT, et al. Geldanamycin induces degradation of hypoxia-inducible factor 1α protein via the proteosome pathway in prostate cancer cells. Cancer Res 2002;62:2478-82.
    • (2002) Cancer Res , vol.62 , pp. 2478-2482
    • Mabjeesh, N.J.1    Post, D.E.2    Willard, M.T.3
  • 7
    • 0037119415 scopus 로고    scopus 로고
    • Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
    • Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway. J Biol Chem 2002;277:29936-44.
    • (2002) J Biol Chem , vol.277 , pp. 29936-29944
    • Isaacs, J.S.1    Jung, Y.J.2    Mimnaugh, E.G.3    Martinez, A.4    Cuttitta, F.5    Neckers, L.M.6
  • 8
    • 10744231706 scopus 로고    scopus 로고
    • 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
    • Mabjeesh NJ, Escuin D, LaVallee TM, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003;4:363-75.
    • (2003) Cancer Cell , vol.4 , pp. 363-375
    • Mabjeesh, N.J.1    Escuin, D.2    LaVallee, T.M.3
  • 9
    • 0035871942 scopus 로고    scopus 로고
    • Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells
    • Chun YS, Yeo EJ, Choi E, et al. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 2001;61:947-54.
    • (2001) Biochem Pharmacol , vol.61 , pp. 947-954
    • Chun, Y.S.1    Yeo, E.J.2    Choi, E.3
  • 10
    • 0036682284 scopus 로고    scopus 로고
    • Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway
    • Rapisarda A, Uranchimeg B, Scudiero DA, et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 2002;62:4316-24.
    • (2002) Cancer Res , vol.62 , pp. 4316-4324
    • Rapisarda, A.1    Uranchimeg, B.2    Scudiero, D.A.3
  • 11
    • 25444523184 scopus 로고    scopus 로고
    • Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
    • Kong D, Park EJ, Stephen AG, et al. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res 2005;65:9047-55.
    • (2005) Cancer Res , vol.65 , pp. 9047-9055
    • Kong, D.1    Park, E.J.2    Stephen, A.G.3
  • 12
    • 0033616948 scopus 로고    scopus 로고
    • Aromatic hydrocarbon nuclear translocator as a common component for the hypoxia- and dioxin-induced gene expression
    • Park H. Aromatic hydrocarbon nuclear translocator as a common component for the hypoxia- and dioxin-induced gene expression. Mol Cells 1999;9:172-8.
    • (1999) Mol Cells , vol.9 , pp. 172-178
    • Park, H.1
  • 13
    • 1242271198 scopus 로고    scopus 로고
    • Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: Mechanism and therapeutic implications
    • Rapisarda A, Uranchimeg B, Sordet O, Pommier Y, Shoemaker RH, Melillo G. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Res 2004;64:1475-82.
    • (2004) Cancer Res , vol.64 , pp. 1475-1482
    • Rapisarda, A.1    Uranchimeg, B.2    Sordet, O.3    Pommier, Y.4    Shoemaker, R.H.5    Melillo, G.6
  • 14
    • 0026580275 scopus 로고
    • Potential antitumor agents. 64. Synthesis and antitumor evaluation of dibenzo [1,4] dioxin-1-carboxamides: A new class of weakly binding DNA-intercalating agents
    • Lee HH, Palmer BD, Boyd M, Baguley BC, Denny WA. Potential antitumor agents. 64. Synthesis and antitumor evaluation of dibenzo [1,4] dioxin-1-carboxamides: a new class of weakly binding DNA-intercalating agents. J Med Chem 1992;35:258-66.
    • (1992) J Med Chem , vol.35 , pp. 258-266
    • Lee, H.H.1    Palmer, B.D.2    Boyd, M.3    Baguley, B.C.4    Denny, W.A.5
  • 15
    • 3843052715 scopus 로고    scopus 로고
    • HIF-1: A target for cancer, ischemia, and inflammation - too good to be true?
    • Melillo G. HIF-1: a target for cancer, ischemia, and inflammation - too good to be true? Cell Cycle 2004;3:154-5.
    • (2004) Cell Cycle , vol.3 , pp. 154-155
    • Melillo, G.1
  • 17
    • 33746564193 scopus 로고    scopus 로고
    • The hypoxic inducible stress response as a target for cancer drug discovery
    • Welsh SJ, Koh MY, Powls G, The hypoxic inducible stress response as a target for cancer drug discovery. Semin Oncol 2006;4:486-97.
    • (2006) Semin Oncol , vol.4 , pp. 486-497
    • Welsh, S.J.1    Koh, M.Y.2    Powls, G.3
  • 18
    • 33749362031 scopus 로고    scopus 로고
    • Inhibiting hypoxia-inducible factor 1 for cancer therapy
    • Melillo G. Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res 2006;4:601-5.
    • (2006) Mol Cancer Res , vol.4 , pp. 601-605
    • Melillo, G.1
  • 19
    • 13544254815 scopus 로고    scopus 로고
    • Topoisomerase II: Untangling its contribution at the centromere
    • Porter AC, Farr CJ. Topoisomerase II: untangling its contribution at the centromere. Chromosome Res 2004;12:569-83.
    • (2004) Chromosome Res , vol.12 , pp. 569-583
    • Porter, A.C.1    Farr, C.J.2
  • 20
    • 1842480104 scopus 로고    scopus 로고
    • Functional compatibility between isoform α and β of type II DNA topoisomerase
    • Sakaguchi A, Kikuchi A. Functional compatibility between isoform α and β of type II DNA topoisomerase. J Cell Sci 2004;117:1047-54.
    • (2004) J Cell Sci , vol.117 , pp. 1047-1054
    • Sakaguchi, A.1    Kikuchi, A.2
  • 21
    • 12444269092 scopus 로고    scopus 로고
    • Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIα
    • Akimitsu N, Adachi N, Hirai H, et al. Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIα. Genes Cells 2003;8:393-402.
    • (2003) Genes Cells , vol.8 , pp. 393-402
    • Akimitsu, N.1    Adachi, N.2    Hirai, H.3
  • 22
    • 0032509551 scopus 로고    scopus 로고
    • Essential mitotic functions of DNA topoisomerase IIα are not adopted by topoisomerase IIβ in human H69 cells
    • Grue P, Grasser A, Sehested M, et al. Essential mitotic functions of DNA topoisomerase IIα are not adopted by topoisomerase IIβ in human H69 cells. J Biol Chem 1998;273:33660-6.
    • (1998) J Biol Chem , vol.273 , pp. 33660-33666
    • Grue, P.1    Grasser, A.2    Sehested, M.3
  • 23
    • 0031722207 scopus 로고    scopus 로고
    • Differential sensitivities of recombinant human topoisomerase IIα and β to various classes of topoisomerase II-interacting agents
    • Perrin D, van Hille B, Hill BT. Differential sensitivities of recombinant human topoisomerase IIα and β to various classes of topoisomerase II-interacting agents. Biochem Pharmacol 1998;56:503-7.
    • (1998) Biochem Pharmacol , vol.56 , pp. 503-507
    • Perrin, D.1    van Hille, B.2    Hill, B.T.3
  • 24
    • 0034193276 scopus 로고    scopus 로고
    • Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs
    • Ogiso Y, Tomida A, Lei S, Omura S, Tsuruo T. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs. Cancer Res 2000;60:2429-34.
    • (2000) Cancer Res , vol.60 , pp. 2429-2434
    • Ogiso, Y.1    Tomida, A.2    Lei, S.3    Omura, S.4    Tsuruo, T.5
  • 25
    • 2942733275 scopus 로고    scopus 로고
    • DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1α in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX
    • Kaluzova M, Kaluz S, Lerman MI, Stanbridge EJ. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1α in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Mol Cell Biol 2004;24:5757-66.
    • (2004) Mol Cell Biol , vol.24 , pp. 5757-5766
    • Kaluzova, M.1    Kaluz, S.2    Lerman, M.I.3    Stanbridge, E.J.4
  • 26
    • 0023887575 scopus 로고    scopus 로고
    • Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides
    • Palmer BD, Rewcastle GW, Atwell GJ, Baguley BC, Denny WA. Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides. J Med Chem 1998;31:707-12.
    • (1998) J Med Chem , vol.31 , pp. 707-712
    • Palmer, B.D.1    Rewcastle, G.W.2    Atwell, G.J.3    Baguley, B.C.4    Denny, W.A.5
  • 27
    • 0035300559 scopus 로고    scopus 로고
    • Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine- 4-carboxamide and DNA-intercalating analogues
    • Osman S, Rowlinson-Busza G, Luthra SK, et al. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine- 4-carboxamide and DNA-intercalating analogues Cancer Res 2001;61:2935-44.
    • (2001) Cancer Res , vol.61 , pp. 2935-2944
    • Osman, S.1    Rowlinson-Busza, G.2    Luthra, S.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.